Strategic BD Analytics Leader for Valuation & Deals

Bristol Myers Squibb; Princeton (NJ); On-site; USD 152,000 - 184,000; Full time

Job summary

Bristol Myers Squibb in Princeton, NJ is hiring a Senior Manager, Business Development Analytics to conduct financial analyses of BD&A opportunities and provide valuation insights for strategic decisions. You will integrate analytics across teams to optimize R&D and portfolio planning, leveraging expertise in statistics, forecasting, and risk assessment.

The role requires a strong background in forecasting, financial modeling, and decision analysis within the pharmaceutical industry, with clear

Qualifications

• Minimum five (5) years of forecasting, financial modeling, valuation or decision analysis experience.
• Experience using probability for revenue risk adjustments is highly preferred in pharma.
• Strong ability to clearly communicate insights to senior management.

Responsibilities

• Lead/facilitate development strategies and analyses for further options.
• Perform financial analyses of development options to inform value-driven decisions.
• Communicate findings clearly to development teams and senior management.
• Integrate cross-analytic services to maximize value from analytics capabilities.
• Stay updated on decision analysis and risk assessment developments.

Skills

Forecasting

Financial modeling

Valuation

Decision analysis

Pharmaceutical industry exp

Communication to senior management

Education

Bachelor's degree in a quantitative discipline

Graduate degree preferred in quantitative discipline

Tools

Excel

Job description

Bristol Myers Squibb in Princeton, NJ is hiring a Senior Manager, Business Development Analytics to conduct financial analyses of BD&A opportunities and provide valuation insights for strategic decisions. You will integrate analytics across teams to optimize R&D and portfolio planning, leveraging expertise in statistics, forecasting, and risk assessment.

The role requires a strong background in forecasting, financial modeling, and decision analysis within the pharmaceutical industry, with clear